THE ORIGIN OF THE 'TRANSMISSION' OF AIDS
By Roberto Giraldo
September 2000
The transmission of AIDS from person to person is a
myth. The homosexual transmission of AIDS in Western countries,
as well as the heterosexual transmission of AIDS in Africa and in
other underdeveloped countries- is an assumption without any
scientific validation.
There is not logic neither scientific explanation for AIDS to be mostly "transmitted"
homosexually
in the West and "heterosexually" in poor countries. The sexual transmission of AIDS has
been
assumed based on the high frequency by which AIDS occurs on drug addicted gay
males in the
developed world, and by the similar frequency of the syndrome in both sexes within the
underdeveloped countries.
Whenever there is an outbreak of new disease, the first question to answer is: What
are the new
circumstances surrounding the individuals who are getting the new illness.
In the report of the first 5 cases of AIDS to the CDC by Michael Gottlieb in June, 1981,
he
informed that "Four had serologic evidence of past hepatitis B infection" "Two of the
five reported
having frequent homosexual contacts with various partners" "All 5 patients had
laboratory-confirmed CMV disease or virus shedding within 5 months of the diagnosis of
Pneumocystis pneumonia" "All five reported using inhalant drugs, and one reported
parental drug
abuse" (Gottlieb et al MMWR 1981; 30:250-252).
There is nothing in this report that could suggest a sexually transmissible germ as the
cause for
the new condition. Homosexuality has existed forever! The new circumstances around
the people
who were getting a collapse of their immune systems, was the use of drugs by some
members of
the gay community in USA and Europe, that began in the late sixties and early
seventies. The
toxic character of AIDS can be seen since the very first report of the new syndrome.
There was
not a need for a microbe to be the cause of the new toxic condition.
However, the Centers for Disease Control (CDC) decided in the Editorial note to
comment
Gottlieb's report that "The fact that these patients were all homosexuals suggests an
association
between some aspect of homosexual lifestyle or disease acquired through sexual
contact and
Pneumocystis pneumonia in this population" (MMWR 1981; 30:250-252).
Even long before HIV was discovered and proposed as the cause of AIDS, the US
Public Health
Service decided the contagious character of the new syndrome. On November 5, 1982
the CDC
wrote "AIDS: Precautions for Clinical and Laboratory Staffs" (MMWR 1982;
31:577-580). Four
months later the CDC, together with the Food and Drug Administration and the National
Institutes
of Health, regulated the prevention of AIDS as if it were an infectious and transmissible
disease
(MMWR 1983; 32:101-104). They decided that AIDS was infectious and sexually
transmitted
without having any scientific proof for it.
In his recent book Luc Montagnier confesses: "It was in 1982 that AIDS began to
capture the
attention of researchers. By that time we knew, by the number of reported cases
among
homosexuals, that we were dealing with a communicable disease" (Montagnier L. Virus:
The
Co-Discoverer of HIV Tracks Its Rampage and Charts the Future; New York: WW
Notton & Co.,
2000: page42).
Robert Gallo writing upon "The AIDS Virus" in 1987 accuses:
"AIDS is probably the result of a new infection of human beings
that began in Central Africa, perhaps as recently as the 1950's" "It
appears that the virus has had more time to spread in Africa than
it has had in any other part of the world" Regarding the so-called
T-lymphotropic virus III (STLV-III) of African green monkeys, he
said "A plausible hypothesis is that STLV-III somehow entered
human beings, initiating a series of mutations that yielded the
intermediate viruses before terminating in the fierce pathology of
HTLV-III" (Gallo R. Scientific America 1987; 256:47-56).
The above are the supposedly "scientific" basis for the infectious
and contagious view upon AIDS.
Researchers and the institutions searching for the cause of AIDS in the early 1980's
and that still
are the ones that make the policies for AIDS worldwide, seem to ignore that there
exist
epidemics of toxic diseases, epidemics of nutritional deficiencies, epidemics of high
blood
pressure, epidemics of cancer, epidemics of mental diseases, epidemics of allergies,
etc. They
can only think about epidemics of infectious diseases. Also, it seems as if they all
ignored that
regular diseases can affect gay people.
These researchers and their institutions are impregnated with a microbiologic prejudice,
by which
all diseases should be caused by germs. Gallo and Montagnier have both spent most of
their
lives searching for the virus that causes cancer.
It is not necessary to make emphasis in the ethnic and sexual prejudices also
expressed by the
above statements.
The world was prepared throughout a century of panic to the microbes,
and by other prejudices to commit the mistake about the etiology of
AIDS. There was no way to avoid it. Similar errors have been committed
with pellagra, beriberi, and scurvy, to mention just a few examples.
Logically, this time the consequences of the mistake are much more
tragic.
All individuals on earth have sexual activity. Similarly all people eat or sleep. The
epidemiological
correlation of AIDS with sexual life as well as, with eating or sleeping is perfect.
Therefore, in the
same way that it is said that AIDS is sexually transmitted, it could be said that it is
transmitted
throughout eating or sleeping.
During the last decades, the new circumstances surrounding gay males who develop
AIDS in the
West are their exposure throughout their life style to drugs of abuse and other
immunological
stressors. In the West, AIDS is mostly confined to male homosexuals, because they
are more
frequently exposed to immunological stressor agents; not because their homosexual
preferences.
Homosexuality has always existed. However, in the late sixties and early seventies gay
male
people in the United States and Europe introduced drugs and aphrodisiacs to their life
styles.
On the other side, the new circumstances surrounding individuals of both sexes in the
poorest
countries of Africa, Asia, and the Caribbean, are their involuntary exposure to - the
never before
seen - high levels of poverty, malnutrition, unsanitary conditions, infections, and
parasites. Here
both sexes are equally exposed to immunological stressor agents. Therefore, in these
countries
the risk for AIDS is equal for both genders.
The perinatal transmission of AIDS from mother to child during pregnancy and delivery;
as well as
the postnatal transmission throughout breast milk are also myths without any scientific
validation.
Both mothers and infants who react positively on the tests for HIV, or who develop
AIDS, do so
due to exposures to immunological stressor agents.
Currently, humans, animals, and plants on earth are all suffering from some
level of immune suppression due to multiple, repeated, and chronic
exposure to the alarming worldwide increment in immunological stressor
agents, which can have a chemical, physical, biological, mental, and
nutritional origin. Immunodeficiency is pandemic.
Individuals can be exposed to immunological stressors involuntarily through
their conditions of life and voluntarily through their life styles.
AIDS is the worst possible immunological human condition: if the course of AIDS is not
stopped,
it will eventually cause the death of the individual. Besides, AIDS is the tip of an
iceberg: bellow
AIDS there are many other mild to moderate immunodeficiencies with or without clinical
manifestations.
AIDS began in the second half of last century, at a moment when the immune systems
of
humans are already saturated and cannot tolerate more challenges and aggravations.
AIDS is an
alarm bell for an endangered species. However, HIV does not permit the real danger to
be seen
and the proper measures to be taken. The increasing epidemic of AIDS in
underdeveloped
countries of Africa and Asia, is demanding strong measures to be taken before the
population of
these continents vanish.
In the seventies a new medical science was born: IMMUNOTOXICOLOGY, which studies
the
effects of toxicants that can poison the immune system. Around thirty years ago
immunologists
began to be preoccupied by the increasing amount of new immunosuppressive
conditions that
animals and humans were suffering, due to voluntary or involuntary exposures to a
great variety of
substances and materials.
Similarly, during the last few decades and due to the alarming worldwide increment in
stressor
agents affecting the human ecosystem, new medical sciences have had to be created:
dermatotoxicology, genotoxicology, neurotoxicology, endocrinotoxicology,
cardiotoxicology,
hepatotoxicology. We may pay attention to this and take the necessary actions to
guaranty the
future of our species. We ought to stop panicking about germs. Currently the real
problems are
toxicants, poverty and malnutrition.
Roberto Giraldo M.D. is a specialist in internal medicine, infectious and tropical diseases, and an independent AIDS researcher. He is living in New York City, and is the president of The Group.
Some references about immunotoxicology:
1973 CUSHMAN P & GRIECO M. Hyperimmunoglobulinemia Associated with Narcotic
Addiction.
Amer J Med 54:320.
1976 ANDERSON RE & WARNER NL. Ionizing Radiation and the Immune Response. Adv
Immunol 24:215.
1977 VOS JG. Immune Suppression as Related to Toxicology. CRC Crit Rev Toxicol 5:67.
1978 BEKESI JG, HOLLAND JF, et al. Lymphocyte Function of Michigan Dairy Farmers
Exposed
to Polybrominated Byphenyls. Science 199:1207.
1979 MOORE JA. The Immunotoxicology Phenomenon. Drug Chem Toxicol 2:1.
1982 DALLY S, WAUTIER J, THOMAS G. Grande Frequence des Complexes Immunes
Circulants Chez les Toxicomanes. Nouv Presse Med 11:1011.
1983 GIBSON GG, HUBBARD R & PARKR DV. Immunotoxicology: Proceedings of the First
International Symposium on Immunotoxicology, Held at the University of Surrey,
England, 13-17
September 1982. London, New York: Academic Press. 505 p.
1986 HOLSAPPE MP & MUNSON AE. Immunotoxicology of Abused Drugs. In: DEAN JH et
al.
Immunotoxicology and Immunopharmacology. New York: Raven Press. P. 381.
1987 SHARMA RP & REDDY RV. Toxic Effects of Chemicals on the Immune System. In:
HALEY TJ & BERNDT WO. Handbook of Toxicology. Washington: Hemisphere Publishing
Corporation. P. 555.
1987 BERLIN A, DEAN J, FRAPER MH, et al. Immunotoxicology. Proceedings of the
International Seminar on the Immunological System as a Target for Toxic Damage.
Dordrecht:
Martinus Nijhoff.
1987 LUSTER MI, BLANK JA & DEAN JH. Molecular and Cellular Basis of Chemical
Induced
Immunotoxicity. Ann Rev Pharmacol Toxicol 27:23.
1988 FIDELIOS RK. The Generation of Oxigen Radicals: A Positive Signal for
Lymphocyte
Activation. Cell Immunol 113:175-182.
1988 WOLFF SP & DEAN RT. Fragmentation of Proteins by Free Radicals and its Effects
on
Their Susceptinility to Enzimatic Hydrolisis. Biochem J 234:399-403.
1988 OLDHAM KT, GUICE KS, WARD PA & JOHNSON JK. The Role of Oxigen Radicals in
Immune Complex Injury. Free Radical Biol Med 4:387-397.
1988 BELLAVITE P. The Superoxide-Forming Enzymatic System of Phagocytes. Free
Radical
Biol Med 4:225-261.
1988 DESCOTES JACQUES. Immunotoxicology of Drugs and Chemicals. Second Edition.
Elsevier: Amsterdam. 450 p.
1988 AHLBOM A. A Review of the Epidemiologic Literature on Magnetic Fields and
Cancer.
Scand J Work Environ Health 14:337-343.
1990 DEAN JH, CORNACOFF JB & LUSTER MI. Toxicity to the Immune System: A
Review. In:
HADDEN JW & SZENTIVANYI A. Immunopharmacology Reviews, Vol 1. New York: Plenum
Press. P. 377.
1991 PRYOR WA & GODBER SS. Oxidative Stress Status: An Introduction. Free Radical
Biol
Med 10:173.
1991 TYRRELL RM. UVA (320-380nm) Radiation as an Oxidative Stress. In: SIES H.
Oxidative
Stress: Oxidants and Antioxidants. London: Academic Press. P. 57-83.
1992 FISCHBEIN A & TARCHER AB. Disorders of the Immune System. In: TARCHER AB.
Priciples and Practice of Environmental Medicine. Part V. Disorders Associated with
Exposure to
Environmental Chemicals and Physical Agents. New York: Plenum Medical Book
Company. P:
389-411.
1992 ANDERSON RE. Effects of Low Dose Radiation on the Immune Response. In:
CALABRESE EJ. Biological Effects of Low Level Exposures to Chemicals and Radiation.
Boca
Raton: Lewis.
1992 MILLER K, TURK JL & NICKLIN S. Principles and Practice of Immunotoxicology.
Boston:
Blackwell Scientific. 379 p.
1993 LAKE JV, BOCK GR & ACKRILL K. Environmental Change and Human Health. Ciba
Foundation Symposium 175. Chichester, New York: John Wiley & Sons. 270 p.
1993 SAHL JD, KELSH MA, GREENLAND S. Cohort and Nested Case Control Studies of
Hematopoietic Cancers and Brain Cancer Among Electric Utility Workers. Epidemiology
4:104.
1993 SLATER TF. Free Radicals: Formation, Detection, Reactivity and Cytotoxicity. In:
LACHMAN PJ et al. Clinical Aspects of Immunology. Fifth Edition, Volume 1. Boston:
Blackwell
Scientific Publications. P. 377-393.
1993 KEHRER JP. Free Radicals as Mediators of Tissue Injury and Disease. Crit Rev
Toxicol
23:21-48.
1994 PRYOR WA. Free Radicals and Lipid Peroxidation: What They are and How They
Got That
Way. In: FREI B. Natural Antioxidants in Human Health and Disease. Chapter 1.
Oxidants and
Antioxidants. San Diego: Academic Press. P. 1-23.
1994 BENDICH A. Role of Antioxidants in the Maintenance of Immune Function. In: FREI
B.
Natural Antioxidants in Human Health and Desease. Chapter IV Immunity and Infection.
San
Diego: Academic Press. P. 447-467.
1994 FRIEDMAN H, SCHIVERS SC, KLEIN TW. Drugs of Abuse and the Immune System.
In:
DEAN JH, et al. Immunotoxicology and Immunopharmacology. New York: Raven Press.
P.
303-322.
1994 WESTER PW, VETHAAK AD & VAN MUISWINKEL WB. Fish as Biomarker in
Immunotoxicology. Toxicology 86(3):213-232.
1994 LUSTER MI, PORTIER C, PAIT DG & GERMOLEC DR. Use of Animal Studies in Risk
Assessment for Immunotoxicology. Toxicology 92(1-3):229-243.
1994 FUCHS BA & SANDERS VM. The Role of Brain-Immune Interactions in
Immunotoxicology.
Crit Rev Toxicol. 24(2):151-176.
1994 SCHUURMAN HJ, KUPER CF & VOS JG. Histopathology of the Immune System as a
Toll
to Assess Immunotoxicity. Toxicology 86(3):187-212.
1994 TRYPHONAS H. Immunotoxicity of Polychlorinated Bephenyls: Present Status and
Future
Considerations. Exp Clin Immunogenet 11(2-3):149-162.
1994 DALE M, FOREMAN JC & FAN TPD. Textbook of Immunopharmacology. Boston:
Blackwell
Scientific Publications. 370 p.
1994 DEAN JH, LUSTER MI, MUNSON AE & KIMBER I. Immunotoxicology and
Immunopharmacology. Second Edition. New York: Raven Press. 761 p.
1995 HORTON WF & GOLBERG S. Power Frequency, Magnetic Fields and Public Health.
Boca
Raton: CRC Press. 276 p.
1995 SZENTIVANYI A, ALI K, ABARCA C, PROCKOP L & BROOKS SM. Environmental
Immunotoxicology. In; BROOKS SM et al. Environmental Medicine. St. Louis: Mosby. P.
139-155.
1995 MACCOA CA, SZENTINANYI A, ALI K, et al. Disorders of the Immune System. In:
BROOKS SM et al. Environmental Medicine. St. Louis: Mosby. P. 326-350.
1996 RODGERS K. Biology of the Immune System and Immunotoxicity. In: FAN AM,
CHANG
LW. Toxicology and Risk Assessment: Principles, Methods, and Applications. New York:
Marcel
Dekker. P. 71-80.
1996 BURNS LA, MEADE BJ & MUNSON AE. Toxic Responses of the Immune System. In:
KLAASEN CD, AMDUR MO, DOULL J. Casarett and Doull's Toxicology: The Basic Science
of
Poisons. Fifth Edition. Unit 4.12. New York: McGraw Hill. P. 355-401.
1996 LUSTER MI. Immunotoxicology: Clinical Consequences. Toxicol Ind Health
12(3-4):533-535.
1996 DE SWART RL, ROSS PS, VOS JG & OSTERHOUS AD. Impaired Immunity in Harbour
Seals (Phoca vitulina) Exposed to Bioaccumulated Environmental Contaminants: Review
of a
Long-Term Feeding Study. Environ Health Perspect 104 Suppl 4:823-828.
1997 SAINT-REMY JM.Epitope Mapping: A New Method for Biological Evaluation and
Immunotoxicology. Toxicology 119(1):77-81.
1997 HOUSE RV, THOMAS PT & BHARGAVA HN. Immunotoxicology of Opioids, Imhalants
and
Other Drugs of Abuse. NIDA Res Monog # 173 p175-200.
1997 NEAUNE PH & LECOEUR S. Immunotoxicology of the Liver: Adverse Reactions to
Drugs. J
Hepatol 26 Suppl 2:37-42.
1998 VANDEBRIEL RJ, VAN LOVEREN H & MEREDITH C. Altered Cytokine (Receptor)
mRNA
Expression as a Tool in Immunotoxicology. Toxicology 130 (1):43-67.
1998 THOMAS PT. Immunotoxicology: Hazard Identification and Risk Assessment. Nutr
Rev 56(1
Pt 2) pS131-134.
1998 BIAGINI RE. Epidemiology Studies in Immunotoxicity Evaluations. Toxicology
129(1):37-54.
1998 ZELIKOFF JT. Biomarkers of Immunotoxicity in Fish and Other Non-Mammalian
Sentinel
Species: Predictive Value for Mammals? Toxicology 129(1):63-71.
1998 KIMBER I & SELGRADE MJK. T Lymphocyte Subpopulations in Immunotoxicology.
Chichester: John Wiley & Sons. 302 p.
1998 VAN LOVEREN H, GERMOLEC D, KOREN HS, LUSTER MI, NOLAN C, REPETTO R,
SMITH E, VOS JG & VOGT RF. Report of the Bilthoven Symposium: Advancement of
Epidemiological Studies in Assessing the Human Health Effects of Immunotoxic Agents
in the
Environment and the Workplace. International Program on Chemical Safety
(UNEP-ILO-WHO),
the World Resources Institute (Washington, DC), the European Science Foundation,
the National
Institute of Environmental Health Sciences (USA), the Environmental Protection
Agency (USA),
the National Institute for Occupational Safety and Health (USA), CDC (USA), and the
American
Crop Protection Association (Washington DC). November 12-14, 1997, Bilthoven, The
Netherlands. RIVM, National Institute of Public Health and the Environment. Bilthoven,
The
Nederlands. RIVM, P.O. Box 1, 3720 BA Bilthoven. Tel 31 30 2749111. Fax 31 30
2742971.